Content area

|
|

Hypofyseadenom

Forfatter(e)
Morten Winkler Møller1, 2, 3, Marianne Skovsager Andersen4, Dorte Glintborg2, 4, Christian Bonde Pedersen1, 2, 3, Bo Halle1, 2, 3,
Bjarne Winther Kristensen2, 5 & Frantz Rom Poulsen1, 3 1) Neurokirurgisk Afdeling, Odense Universitetshospital 2) Klinisk Institut, Syddansk Universitet3) BRIDGE - Brain Research - Inter-
Disciplinary Guided Excellence, Klinisk Institut, Syddansk Universitet 4) Endokrinologisk Afdeling, Odense Universitetshospital 5) Patologisk Afdeling, Odense Universitets-hospital

Ugeskr Læger 2019;181:V05180331

Reference: 
Ugeskr Læger 2019;181:V05180331
Blad nummer: 
Sidetal: 

Morten Winkler Møller, Marianne Skovsager Andersen, Dorte Glintborg, Christian Bonde Pedersen, Bo Halle, Bjarne Winther Kristensen & Frantz Rom Poulsen:

Pituitary adenoma

Ugeskr Læger 2019;181:V05180331

In this review, we discuss pituitary adenomas (PA), which account for 10-25% of the intracranial tumours. Despite their benign nature, PA often show invasive growth. Pressure on neighbouring structures may cause hypopituitarism or vision field impairment. For PA, except prolactinomas, surgical treatment is first choice. The primary surgical technique is transsphenoidal surgery. Pituitary function, vision and post-operative magnetic resonance imaging scan is evaluated in a multidisciplinary team of neurosurgeons and endocrinologist 6-8 weeks post-operatively. Follow-up and treatment of pituitary adenomas is highly specialised and requires a team of dedicated endocrinologists and neurosurgeons.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Erik Kristensen | 17/01
20 kommentarer
af Thomas Michael Dan Aru | 17/01
4 kommentarer
af Claus Rasmussen | 17/01
1 Kommentar
af Claus Bo Svenningsen | 15/01
1 Kommentar
af Lars Kambjerre | 14/01
6 kommentarer
af Camilla Bang | 12/01
12 kommentarer